<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Although it is known that the prevalence of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and <z:hpo ids='HP_0001513'>obesity</z:hpo> is increasing in China, there is little research into how <z:mp ids='MP_0001261'>obese</z:mp> or non-<z:mp ids='MP_0001261'>obese</z:mp> patients may differ in their attainment of treatment goals for type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>To do this, we assessed the attainment of American <z:mp ids='MP_0002055'>Diabetes</z:mp> Association (<z:chebi fb="36" ids="39048">ADA</z:chebi>)-recommended goals in Chinese with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> stratified by body mass index (BMI) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: This cross-sectional study enrolled 520 Chinese with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> to find out if they had attained the following <z:chebi fb="36" ids="39048">ADA</z:chebi>-recommended goals: HbA1c&lt;7%, SBP&lt;130 mm Hg, <z:chebi fb="4" ids="35861">DBP</z:chebi>&lt;80 mm Hg, <z:chebi fb="0" ids="47774">LDL-C</z:chebi>&lt;100mg/dl, TG&lt;150 mg/dl, <z:chebi fb="0" ids="47775">HDL-C</z:chebi>&gt;40 mg/dl for men and &gt;50mg/dl for women </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Only 44.4% of <z:hpo ids='HP_0000001'>all</z:hpo> participants achieved the blood pressure goal, 20.8% the HbA1c goal, 44.8% the <z:chebi fb="0" ids="47774">LDL-C</z:chebi> goal, 43.3% the <z:chebi fb="0" ids="47775">HDL-C</z:chebi> goal, and 66.8% the <z:chebi fb="0" ids="17855">triglyceride</z:chebi> goal </plain></SENT>
<SENT sid="4" pm="."><plain><z:mp ids='MP_0001261'>Obese</z:mp> patients were less likely than <z:mpath ids='MPATH_458'>normal</z:mpath> weight patients to achieve the blood pressure goal (OR, 0.474; 95% CI, 0.231-0.973; p = 0.01), the <z:chebi fb="17" ids="39025">HDL</z:chebi> goal (OR, 0.365; 95% CI, 0.163-0.817; p = 0.01), or the <z:chebi fb="0" ids="17855">triglyceride</z:chebi> goal (OR, 0.416; 95% CI, 0.212-0.817; p = 0.01), after adjusting for confounders </plain></SENT>
<SENT sid="5" pm="."><plain>Compared to <z:mpath ids='MPATH_458'>normal</z:mpath> weight participants, the <z:mp ids='MP_0001261'>obese</z:mp> patients had a significantly higher prescription rates for <z:chebi fb="0" ids="35664">statin</z:chebi>, <z:chebi fb="0" ids="6801">metformin</z:chebi> and anti-hypertensive drugs </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: <z:mp ids='MP_0001261'>Obese</z:mp> diabetic patients were less likely to achieve the blood pressure, <z:chebi fb="0" ids="47774">LDL-C</z:chebi>, <z:chebi fb="0" ids="47775">HDL-C</z:chebi> and <z:chebi fb="0" ids="17855">triglyceride</z:chebi> targets even when they were receiving several drugs to help them meet their target treatment goals </plain></SENT>
<SENT sid="7" pm="."><plain>More strategies are needed to improve the treatment of Chinese with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, particularly those who are <z:mp ids='MP_0001261'>obese</z:mp> </plain></SENT>
</text></document>